ZNF861P

Across TCGA pan-cancer cohorts, ZNF861P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ZNF861P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where ZNF861P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF861P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BLCA, THCA, and READ are the cancer types where ZNF861P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF861P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.251	.006	6	view →
THCA	Female	All	−0.030	.014	2	view →
READ	All	All	+0.120	.043	1	view →
LUAD	Female	All	+0.061	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ZNF861P–BLCA

Open the BLCA breakdown →